Newsouth Innovations Pty Limited

University of Nottingham

Exonate Limited

Metro International Biotech, LLC

Jonathan Morris

David Owen Bates

Andrew David Morley

Andrew Douglas Baxter

Hamish Toop

Bruce G Szczepankiewicz

Jonathan N Kremsky

Jennifer Batson

Steven James Harper

Melissa Gammons

Anti-angiogenic treatments, for example treatment of ocular neovascularization or cancer, treatments of hyperpermeability disorders, treatments of neuropathic and neurodegenerative disorders, pain treatments, methods of treating or preventing fibrosis and compounds for use in such methods are described.

SRPK1 inhibitors

Anti-angiogenic treatments and compounds for use in anti-angiogenic treatments, particularly of conditions associated with abnormal angiogenesis or abnormal over-production of pro-angiogenic VEGFxxx isoforms in or on the eye are described.

1-methyl-1H-pyrazol-3-yl derivatives for use in the treatment of neovascular diseases

Provided herein are compounds of Formula (I) and their salts, and compositions comprising such compounds that are useful for increasing the amount of NADin cells. Also disclosed are methods of using the disclosed compounds and compositions for treating, for example, diseases or disorders related to aging or stress, diabetes, obesity, mitochondrial diseases, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing.

Nicotinamide riboside analogs, pharmaceutical compositions, and uses thereof

Compounds

Anti-angiogenic treatments, treatments of hyperpermeability disorders, treatments of neuropathic and neurodegenerative disorders, pain treatments, methods of reducing the risk of pre-eclampsia and compounds for use in such methods are described.

Compounds useful for treating ocular neovasculan

Piperazine derivatives for treating disorders

Growing community of inventors

New South Wales, Australia

Jonathan Morris